Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/17413
ชื่อเรื่อง: Coronavac covid-19 vaccine-induced anaphylaxis: Clinical characteristics and revaccination outcomes
ผู้แต่ง: Laisuan W.
Wongsa C.
Chiewchalermsri C.
Thongngarm T.
Rerkpattanapipat T.
Iamrahong P.
Ruangwattanachok C.
Nanthapisal S.
Sompornrattanaphan M.
Keywords: coronavac
immunoglobulin G
inactivated vaccine
adult
anaphylaxis
Article
Burkholderia pseudomallei
clinical article
complement activation
coronavirus disease 2019
drug hypersensitivity
fatigue
female
fever
genetic variation
headache
human
intensive care unit
middle aged
mortality
myalgia
nose polyp
petechia
prick test
revaccination
shellfish allergy
treatment outcome
vaccination
วันที่เผยแพร่: 2021
บทคัดย่อ: Anaphylaxis to CoronaVac, an inactivated vaccine against COVID-19, is extremely rare. We report 12 cases of anaphylaxis after CoronaVac administration, focusing on clinical characteristics and management outcomes. Skin test and graded vaccine challenge were successfully performed in our cases and might be considered if an inactivated vaccine is the only remaining option. © 2021 Laisuan et al. This work is published and licensed by Dove Medical Press Limited.
URI: https://ir.swu.ac.th/jspui/handle/123456789/17413
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85118542385&doi=10.2147%2fJAA.S333098&partnerID=40&md5=ea53204c87f5a790f324985731619e81
ISSN: 11786965
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.